NOL7 is a nucleolar candidate tumor suppressor gene in cervical cancer that modulates the angiogenic phenotype

Cervical cancer is associated with human papilloma virus infection. However, this infection is insufficient to induce transformation and progression. Loss of heterozygosity analyses suggest the presence of a tumor suppressor gene (TSG) on chromosome 6p21.3–p25. Here we report the cloning NOL7, its mapping to chromosome band 6p23, and localization of the protein to the nucleolus. Fluorescence in situ hybridization analysis demonstrated an allelic loss of an NOL7 in cultured tumor cells and human tumor samples. Transfection of NOL7 into cervical carcinoma cells inhibited their growth in mouse xenografts, confirming its in vivo tumor suppressor activity. The induction of tumor dormancy correlated with an angiogenic switch caused by a decreased production of vascular endothelial growth factor and an increase in the production of the angiogenesis inhibitor thrombospondin-1. These data suggest that NOL7 may function as a TSG in part by modulating the expression of the angiogenic phenotype.

[1]  H. Shiku,et al.  Acute promyelocytic leukemia with del(6)(p23). , 2000, Leukemia research.

[2]  Yusuke Nakamura,et al.  Identification of NOL8, a nucleolar protein containing an RNA recognition motif (RRM), which was overexpressed in diffuse‐type gastric cancer , 2004, Cancer science.

[3]  K. Dameron,et al.  Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity , 1997, Oncogene.

[4]  T. Inaba,et al.  Deletion 6p23 and add(11)(p15) leading to NUP98 translocation in a case of therapy-related atypical chronic myelocytic leukemia transforming to acute myelocytic leukemia. , 2004, Cancer genetics and cytogenetics.

[5]  T. Kinoshita,et al.  Identification and mapping of novel tumor suppressor loci on 6p in diffuse large B‐cell non‐Hodgkin's lymphoma , 1999, Genes, chromosomes & cancer.

[6]  G. Fleuren,et al.  Allelic loss and prognosis in carcinoma of the uterine cervix , 1998, International journal of cancer.

[7]  J. Niloff,et al.  Cancer of the uterine cervix. , 1996, The New England journal of medicine.

[8]  J. Peto,et al.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide , 1999, The Journal of pathology.

[9]  A. Brothman,et al.  Nonrandom rearrangements of 6p in malignant hematological disorders. , 2000, Cancer genetics and cytogenetics.

[10]  Mei-Ling Kuo,et al.  Nucleolar Arf tumor suppressor inhibits ribosomal RNA processing. , 2003, Molecular cell.

[11]  P. Bornstein,et al.  The Wilms' tumor gene product represses the transcription of thrombospondin 1 in response to overexpression of c-Jun , 1999, Oncogene.

[12]  Michael P. Myers,et al.  PTEN controls tumor-induced angiogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  S. Srivastava,et al.  The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell lines. , 1992, Carcinogenesis.

[14]  J. McDougall,et al.  Genetic instability of chromosome 3 in HPV‐immortalized and tumorigenic human keratinocytes , 1995, Genes, chromosomes & cancer.

[15]  A. Albini,et al.  c-fos-induced growth factor/vascular endothelial growth factor D induces angiogenesis in vivo and in vitro. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  N. Bouck,et al.  The angiogenic switch in hamster buccal pouch keratinocytes is dependent on TGFbeta-1 and is unaffected by ras activation. , 1997, Carcinogenesis.

[17]  P. Steeg,et al.  Expression of the extracellular matrix molecule thrombospondin inversely correlates with malignant progression in melanoma, lung and breast carcinoma cell lines , 1994, International journal of cancer.

[18]  K. Mitsuya,et al.  Normal human chromosome 2 induces cellular senescence in the human cervical carcinoma cell line SiHa , 1995, Genes, chromosomes & cancer.

[19]  Visintin,et al.  The nucleolus: the magician's hat for cell cycle tricks , 2000, Current opinion in cell biology.

[20]  M. Dundr,et al.  The nucleolus: an old factory with unexpected capabilities. , 2000, Trends in cell biology.

[21]  N. Sheibani,et al.  Repression of thrombospondin-1 expression, a natural inhibitor of angiogenesis, in polyoma middle T transformed NIH3T3 cells. , 1996, Cancer letters.

[22]  P. Lazo,et al.  The molecular genetics of cervical carcinoma , 1999, British Journal of Cancer.

[23]  R. Weinberg,et al.  Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. , 2003, Cancer cell.

[24]  J. Wolf,et al.  The Molecular Biology of Cervical Cancer , 2001, Cancer investigation.

[25]  N. Bouck,et al.  How tumors become angiogenic. , 1996, Advances in cancer research.

[26]  M. Dyer,et al.  Myeloid‐ and lymphoid‐specific breakpoint cluster regions in chromosome band 13q14 in acute leukemia , 1999, Genes, chromosomes & cancer.

[27]  O. Volpert,et al.  Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  L. DiPietro,et al.  Wound healing : methods and protocols , 2003 .

[29]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[30]  R. Klausner,et al.  Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  M. Linial,et al.  Viral Myc Oncoproteins in Infected Fibroblasts Down-modulate Thrombospondin-1, a Possible Tumor Suppressor Gene* , 1996, The Journal of Biological Chemistry.

[32]  D. Gerhard,et al.  Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features. , 1998, Human pathology.

[33]  D. Gerhard,et al.  Cervical cancer suppressor gene is within 1 cM on 6p23 , 2000, Genes, chromosomes & cancer.

[34]  Charles J. Sherr,et al.  Nucleolar Arf sequesters Mdm2 and activates p53 , 1999, Nature Cell Biology.